We are live on !
Find out more
Parallel Advisors Portfolio holdings
AUM
$7.42B
Turnover
9.77%
1-Year Est. Return
27.68%
Parallel Advisors is a wealth manager that puts financial planning first, with in-house tax and trust services and a family office. It was founded in 2006 and is led by chief executive Jerry Rendic, with Prism Topco as its principal owner. The firm sells no products of its own, so its advisors can pick from outside funds, including low-cost index funds. It works with families and institutions.
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+27.68%
3 Year Est. Return
+122.34%
5 Year Est. Return
+126.9%
10 Year Est. Return
+398.12%
AUM
$7.42B
AUM Growth
+$855M
(+13%)
Cap. Flow
+$618M
Cap. Flow % of AUM
Cap. Flow %
8.34%
Top 10 Holdings %
Top 10 Hldgs %
37.36%
Holding
4,186
New
256
Increased
1,963
Reduced
1,120
Closed
153
Avg Time Held
Equity + Options
4.9
years
Top 10 Avg Time Held
Equity + Options
4
years
Top 20 Avg Time Held
Equity + Options
4.7
years
Avg Time Held Equity only
4.9
years
Top 10 Avg Time Held Equity only
4
years
Top 20 Avg Time Held Equity only
4.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
|
+$50.8M |
| 2 |
iShares International Country Rotation Active ETF
CORO
|
+$41.6M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$35.7M |
| 4 |
PIMCO Multi Sector Bond Active ETF
PYLD
|
+$32.5M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust WCM International Equity ETF
WCMI
|
+$14.1M |
| 2 |
Avantis International Equity ETF
AVDE
|
+$7.51M |
| 3 |
Corcept Therapeutics
CORT
|
+$6.41M |
| 4 |
Crown Castle
CCI
|
+$6.2M |
| 5 |
VictoryShares Free Cash Flow ETF
VFLO
|
+$4.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.31% |
| 2 | Technology | 17.75% |
| 3 | Healthcare | 9.55% |
| 4 | Financials | 5.39% |
| 5 | Communication Services | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3426
Capricor Therapeutics
CAPR
$479M
| $3.79K | ﹤0.01% |
400
+153
| +62% | +$1.69K |
2025 Q4
3 quarters
|
|
3427
Allot
ALLT
$408M
| $3.78K | ﹤0.01% |
448
-204
| -31% | -$1.63K |
2026 Q2
1 quarter
|
|
3428
Empire State Realty Trust
ESRT
$874M
| $3.78K | ﹤0.01% |
937
+453
| +94% | +$2.19K |
2026 Q2
1 quarter
|
|
3429
Newmark Group
NMRK
$2.16B
| $3.78K | ﹤0.01% |
308
-346
| -53% | -$5.17K |
2019 Q4
27 quarters
|
|
3430
Latham Group
SWIM
$861M
| $3.74K | ﹤0.01% |
601
+354
| +143% | +$2.29K |
2025 Q1
6 quarters
|
|
3431
Onterris Inc
ONT
$551M
| $3.73K | ﹤0.01% |
279
+97
| +53% | +$1.77K |
2025 Q1
6 quarters
|
|
3432
Merchants Bancorp
MBIN
$2.38B
| $3.72K | ﹤0.01% |
76
+45
| +145% | +$2.33K |
2022 Q2
17 quarters
|
|
3433
Embotelladora Andina Series B
AKO.B
$4.5B
| $3.72K | ﹤0.01% |
128
+98
| +327% | +$2.95K |
2025 Q2
5 quarters
|
|
3434
JPMorgan Realty Income ETF
JPRE
$480M
| $3.71K | ﹤0.01% |
75
| – | – |
2026 Q1
2 quarters
|
|
3435
Immunovant
IMVT
$6B
| $3.65K | ﹤0.01% |
108
| – | – |
2024 Q4
7 quarters
|
|
3436
Garrett Motion
GTX
$3.83B
| $3.64K | ﹤0.01% |
140
| – | – |
2021 Q3
20 quarters
|
|
3437
iRhythm Holdings
IRTC
$4.17B
| $3.64K | ﹤0.01% |
32
| – | – |
2021 Q3
20 quarters
|
|
3438
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.14B
| $3.64K | ﹤0.01% |
+170
| New | +$3.86K |
2026 Q3
0 quarters
|
|
3439
Century Aluminum
CENX
$3.3B
| $3.6K | ﹤0.01% |
100
-74
| -43% | -$3.27K |
2022 Q3
16 quarters
|
|
3440
Herbalife
HLF
$1.51B
| $3.59K | ﹤0.01% |
296
+193
| +187% | +$2.37K |
2025 Q1
6 quarters
|
|
3441
JBT Marel
JBTM
$6.12B
| $3.59K | ﹤0.01% |
34
+17
| +100% | +$2.11K |
2024 Q2
9 quarters
|
|
3442
Perpetua Resources
PPTA
$2.01B
| $3.58K | ﹤0.01% |
166
+12
| +8% | +$266 |
2026 Q1
2 quarters
|
|
3443
Harmony Biosciences
HRMY
$2.16B
| $3.57K | ﹤0.01% |
91
| – | – |
2023 Q4
11 quarters
|
|
3444
Great Southern Bancorp
GSBC
$888M
| $3.55K | ﹤0.01% |
46
| – | – |
2020 Q4
23 quarters
|
|
3445
Arqit Quantum
ARQQ
$261M
| $3.52K | ﹤0.01% |
146
+24
| +20% | +$496 |
2025 Q2
5 quarters
|
|
3446
Lindblad Expeditions
LIND
$2.15B
| $3.52K | ﹤0.01% |
112
+67
| +149% | +$1.94K |
2026 Q2
1 quarter
|
|
3447
Real REMAX Group Inc. Common Stock
REAX
$332M
| $3.52K | ﹤0.01% |
215
+196
| +1,032% | +$3.95K |
2026 Q2
1 quarter
|
|
3448
Mesa Laboratories
MLAB
$702M
| $3.51K | ﹤0.01% |
27
| – | – |
2026 Q1
2 quarters
|
|
3449
USA Rare Earth Inc
USAR
$3.27B
| $3.49K | ﹤0.01% |
248
-989
| -80% | -$16.8K |
2026 Q2
1 quarter
|
|
3450
Invesco KBW Bank ETF
KBWB
$6.69B
| $3.49K | ﹤0.01% |
40
| – | – |
2026 Q1
2 quarters
|
|
Similar funds
Parallel Advisors's Q3 2026 Portfolio in Review
As of Q3 2026, Parallel Advisors held 4,186 positions worth $7.42B, up 13% from $6.56B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors deployed $618M of net new capital in Q3 2026, opening 256 new positions and adding to 1,963 existing holdings. Its largest new stake was Fidelity International High Dividend ETF: 314,039 shares worth $8.73M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, up from 49% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was First Trust WCM International Equity ETF, an estimated $14.1M trimmed.
- Parallel Advisors's largest Q3 2026 buy was Fidelity International High Dividend ETF: 314,039 shares worth $8.73M.
- Parallel Advisors added most to Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF in Q3 2026, an estimated $50.8M increase.
- Parallel Advisors's biggest Q3 2026 reduction was First Trust WCM International Equity ETF, cutting an estimated $14.1M.
- Parallel Advisors fully exited Electronic Arts in Q3 2026, selling an estimated $1.54M.
- Parallel Advisors's ten largest holdings make up 37% of its $7.42B portfolio in Q3 2026.
- Parallel Advisors opened 256 new positions and closed 153 in Q3 2026.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $7.42B.
Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.